In addition to a high-dose oral version of semaglutide that showed promising effects in trials and is on the horizon for approval, a tsunami of clinical trial results is anticipated for new drugs that also operate on the gut-brain axis and re-create the action of other intestinal and pancreatic hormones
Over 50% of participants dropped 15% of their total body fat, while another 40% of the participants dropped 20% of their body fat
Nausea is the most common, affecting roughly 20 to 44 percent of patients in clinical trials depending on the dose
Fast shipping, easy directions, the packaging was pretty high end
A second MDL involves sudden vision changes, optic nerve damage, loss of peripheral vision, blurred vision, or permanent blindness allegedly associated with NAION following semaglutide use
For many people, these changes happen slowly over weeks or months